MarketScale: Labor shortages are driving growth of wearable heart tech

Biomedical engineering professor explains why new devices are in such high demand

MarketScale turned to a biomedical engineering professor at the University of Cincinnati to explain the high growth of wearable technology in the field of cardiovascular medicine.

UC College of Engineering and Applied Science Professor Jason Heikenfeld said companies are trying to replicate the success of home blood-glucose monitoring for diabetes with other chronic illnesses such as heart disease.

“Cardiovascular disease is coming for all of us,” Heikenfeld told Marketscale. “If you look at the states, at age 60 you have a 50% chance of having cardiovascular disease. It's something that will affect all of us, especially as the population ages.”

In his Novel Device Lab, Heikenfeld and his research team have applied for more than 100 patents on a variety of new sensors and wearable technology.

Heikenfeld said labor shortages in health care are driving the growth of home-health monitoring and wearable technology.

“For hospitals and providers, there’s a huge push to decentralize medicine and get it out of the clinic,” he said. “Doing things in-clinic is costly. And we have an infrastructure bottleneck. So we need to find ways to streamline things and make them more efficient.”

Heikenfeld said researchers working on the next generation of sensors are using the latest glucose monitors for inspiration.

“They are total works of art,” he said. “They’re beautiful. They last for two weeks. They’re disposable. They’re affordable. They’re highly accurate. Patients apply them and most don’t feel any pain or anything whatsoever, so patients are happy with them.”

Watch the MarketScale interview.

Related Stories

1

Struggling with daily HIV meds?

March 23, 2026

For many people living with HIV, staying healthy depends on something deceptively simple: taking a pill every day. But for those navigating unstable housing, stigma, mental health challenges or addiction, that daily routine can be hard to maintain. As Yahoo!Health recently reported, a new study suggests there may be a better option.

2

Extended-release buprenorphine viable, safe during pregnancy

March 23, 2026

MedPage Today highlighted research led by the University of Cincinnati's John Winhusen published in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue.

3

Why are we so unhappy?

March 23, 2026

Suzie White, assistant professor in the School of Education, at the University of Cincinnati, spoke with Newsweek about the results of the 2026 World Happiness Report that placed the United States 23rd among countries.